Welcome to our dedicated page for Upexi SEC filings (Ticker: UPXI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Upexi’s filings can feel like a puzzle—hemp wellness, nutraceutical pills, pet treats, Disney-licensed toys, even crypto mining all live under one roof. Locating segment revenue or the impact of Amazon fees means combing through thousands of lines. If you have ever typed “Upexi insider trading Form 4 transactions” into Google, you already know the challenge.
Stock Titan’s platform turns that maze into a map. Our AI reads every Upexi quarterly earnings report 10-Q filing, flags revenue swings, and highlights inventory write-downs. Need real-time alerts? We stream Upexi Form 4 insider transactions real-time, so you spot executive buys and sells faster. From concise dashboards to one-click downloads, this page delivers Upexi SEC filings explained simply—covering 10-K annual reports, 8-K event notices, and proxy statements that detail executive compensation.
Use cases are immediate: compare hemp gross margins quarter over quarter, monitor Upexi executive stock transactions Form 4 before material events, or trace how restructuring shows up in an Upexi 8-K material events explained alert. Our AI summaries shave hours off Upexi earnings report filing analysis while understanding Upexi SEC documents with AI keeps jargon in check. Whether you want an Upexi annual report 10-K simplified or to review an Upexi proxy statement executive compensation table, every document arrives seconds after EDGAR posts. No more hunting—just the insights that matter across one diversified consumer powerhouse.
Bloom Energy Corp. (BE) – Form 144 filing: Insider Daniel Berenbaum has notified the SEC of his intent to sell 8,000 common shares through Morgan Stanley Smith Barney on 24 Jul 2025. The proposed sale is valued at $262,850, implying an indicative price of roughly $32.86 per share.
The filing also discloses that Berenbaum has already disposed of 48,300 shares over the last three months in eight separate transactions, generating aggregate gross proceeds of approximately $1.02 million. Recent sales include 6,000 shares on 9 Jul 2025 ($168k) and 14,889 shares on 21 May 2025 ($276.9k). No relationship to the issuer is specified in the form, and the signer affirms possession of no undisclosed material adverse information.
While Form 144 only signals an intention to sell and not a completed transaction, investors often view continued insider liquidation—especially following significant recent sales—as a potential negative sentiment indicator.
On 22 Jul 2025 MMCAP International Inc. SPC and its affiliate MM Asset Management Inc. filed a Schedule 13G revealing a sizeable holding in Upexi, Inc. (UPXI).
- Beneficial ownership: 12,941,176 common shares, representing 9.99 % of the outstanding class.
- Power: 0 shares sole voting/dispositive; full power is held jointly over all reported shares.
- Origin of stake: senior convertible notes that can be exchanged for common stock, subject to a 9.99 % conversion cap.
- Trigger date: 16 Jul 2025.
The disclosure indicates meaningful institutional interest while flagging potential dilution should conversion limits change.
On 15 Jul 2025, XBP Americas, LLC, a wholly-owned subsidiary of XBP Europe Holdings, Inc. (Nasdaq: XBP / XBPEW), closed the acquisition of 100% of Exela Technologies BPA, LLC and its subsidiaries (the “BPA Group”) from Exela Technologies, Inc. under the Membership Interest Purchase Agreement signed 3 Jul 2025.
The purchase price was only $1.00 because the BPA Group is operating under Chapter 11 bankruptcy (case “In re DocuData Solutions, L.C.”) and carries substantial encumbrances. The deal is classified as a related-party transaction as both buyer and seller share common ownership.
The transaction contains conditions subsequent: if the bankruptcy reorganization plan is not effective or other conditions are unmet by 7 Aug 2025, XBP can rescind the purchase. The filing provides no pro-forma financials, synergies or earnings guidance.
Key implications: XBP gains potential upside from a distressed asset at minimal cash cost but assumes restructuring risk and faces governance scrutiny due to the affiliated nature of the deal.
Vivakor (VIVK) filed an 8-K disclosing a series of debt restructurings and new borrowings with existing lender J.J. Astor & Co.
- Forbearance & Amendment (7/9/25): Lender agreed to forbear existing defaults, advance up to an additional $4.4 M, and extend the resale registration deadline to 7/18/25. Outstanding principal on the March 2025 junior secured convertible note was reset to $6.77 M (110% of $6.15 M) and a $615k fee plus $291k accrued interest become cash-payable by 1/7/26.
- Additional Junior Secured Convertible Note: Face value $5.94 M, but after a $1.54 M original issue discount, $176k origination fee, $20k legal fees, and $3.23 M holdbacks, net cash received on 7/15/25 was only $0.97 M. The note amortises over 40 weekly $148.5k instalments, payable in cash or registered shares at a 20% discount; default converts at a 50% discount. A junior lien on all assets secures both notes. Company reserved 15 M shares and issued 150k commitment shares.
- Unregistered Equity: Commitment shares and note were issued under Section 4(a)(2) with Rule 144 legends.
Implications: The transactions provide near-term liquidity and forestall default but at significant cost—high fees, steep OID, aggressive share-settlement terms, and further dilution risk.
Constellation Brands (STZ) – Form 4 insider transaction
Richard Sands, a Director and >10% owner, reported the vesting and automatic conversion (code “M”) of 503 restricted stock units into an equal number of Class A common shares on 07/10/2025. No cash was exchanged (exercise price $0). After the transaction, Sands’ direct holdings rose to 503 shares. He also maintains large indirect positions:
- 188,015 shares through RES Master LLC
- 5,066,666 shares through RES Business Holdings LP
- 1,736,884 shares through SER Business Holdings LP
- 15,720 shares held by his spouse
The filing reflects routine incentive-plan vesting rather than open-market buying or selling. Given the small share count relative to Sands’ multi-million-share stake and STZ’s ~200 million-share float, the event is unlikely to have a material impact on valuation or market sentiment.
Key take-away: A group of Attestor-related entities and their principal, Jan-Christoph Peters, have filed a Schedule 13G disclosing passive ownership of Upexi, Inc. (ticker UPXI) common stock.
- Reporting persons: Attestor Value Master Fund LP, Attestor Value Fund GP Ltd, Attestor Capital Ltd, Attestor Ltd and Mr. Peters (together, the “Reporting Persons”).
- Shares owned: 3,419,461 shares of UPXI common stock.
- Ownership percentage: 9.0 % of the outstanding class.
- Voting & dispositive power: 0 shares held with sole power; 3,419,461 shares held with shared voting and dispositive power.
- Date triggering filing: 23 June 2025; filing signed: 11 July 2025.
- Jurisdictions: Operating entities organised in the Cayman Islands; investment-management entity and Mr. Peters domiciled in the United Kingdom.
- Filing basis: Schedule 13G (passive investment); certification states the stake was acquired in the ordinary course and not to influence control.
The filing establishes that the Attestor group is now a 5 %-plus shareholder in Upexi, giving it disclosure obligations under Section 13 of the Exchange Act. No additional financial results, purchase prices or strategic intentions are provided.